📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
2 articles
AVG GRADE
NEUTRAL
score: 0.25
SENTIMENT
NEUTRAL
TOTAL VIEWS
46
LTRN Stock Analysis & AI Grade: NEUTRAL
2 articles analyzed · Sentiment: NEUTRAL · AI-powered equity research
RECENT COVERAGE · 2 ARTICLES
Lantern Pharma outlines Open Medicine AI spin-out amid $10B market outlook by 2030-2031 (NASDAQ:LTRN)
Lantern Pharma disclosed a strategic spin-out of Open Medicine AI, a subsidiary focused on artificial intelligence-driven drug...
Lantern Pharma Inc. (LTRN) Q2 2026 Earnings Call Transcript
LTRN disclosed its Q2 2026 earnings results via transcript publication on Seeking Alpha, representing a routine earnings call disclosure...
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice